Sector stalwarts like Amgen (NASDAQ: AMGN ), Pfizer (NYSE: PFE ) and Regeneron Pharmaceuticals (NASDAQ: REGN ) have no direct rival to AbbVie's flagship. Most of the $867 billion farm bill is aimed at supporting the U.S. agricultural industry, which has been buffeted by commodity price deflation as a trade war escalated this year. Pro #3: Business-first Mentality Boosts AbbVie Stock A recent Bloomberg article had an interesting take on Gilead Sciences (NASDAQ: GILD ).